Analysis of the General Development Trends and the Level of Digitization of the Pharmaceutical Market in the Russian Federation

  • A. L. BeloborodovaEmail author
  • N. G. Antonchenko
  • A. V. PavlovaEmail author
  • A. D. Hajrullina
  • A. A. Soldatov
Conference paper
Part of the Advances in Intelligent Systems and Computing book series (AISC, volume 908)


The paper presents a brief overview of companies that form analytical databases on the Russian pharmaceutical market. On the basis of information from four such databases and independently conducted field research, which involved Russian and foreign manufacturers of originator drugs and generics in Russia and abroad, the main trends in the development of the Russian pharmaceutical market are presented. Particular attention is paid to the analysis of trends implementing innovative technologies and digital tools in the activities of companies targeting the pharmaceutical market.


Innovative technologies Pharmaceutical market Russian pharmaceutical market Pharmacy Digital technologies 


  1. 1.
    Antonchenko N, Kalenskaya N (2014) Developing a methodology for assessing the efficacy of managerial decisions in entrepreneurial establishments. Life Sci J 11(7):365–369Google Scholar
  2. 2.
    Beloborodova AL, Martynova OV (2016) The development of the trade industry in Russia: trends, problems and prospects. Bull Volga State Technol Univ 1(29):53–60Google Scholar
  3. 3.
    Bondarev AV, Linnikova OV, Novikova NB (2016) Overview of the Russian pharmaceutical market. New Sci Curr State Ways Dev 8:117–120Google Scholar
  4. 4.
    Chamberlin EH (1951) Monopolistic competition revisinted. Economica 18:343–362CrossRefGoogle Scholar
  5. 5.
    Denisova OV (2016) Key trends in the development of the pharmaceutical market in Russia. Econ Entrepreneurship 4–1(69–1):1163–1168Google Scholar
  6. 6.
    Fedorova YuV, Fedotova LS (2015) Import substitution as a factor in the development of the Russian pharmaceutical market. Bulletin of Udmurt University. Ser Econ Law 6:55–58Google Scholar
  7. 7.
    Hotelling H (1921) Stability in competition. Econ J 39:41–57CrossRefGoogle Scholar
  8. 8.
    Lin AA, Sokolov BI, Slepnev DM (2013) Pharmaceutical market: the production of drugs in Russia. Prob Mod Econ 1(45):191–195Google Scholar
  9. 9.
    Narkevich IA, Lin AA, Orlov AS (2015) The level and price dynamics in the commercial retail sector of the pharmaceutical market in Russia and St. Petersburg. Pharmacy 4:28Google Scholar
  10. 10.
    Olkhovskaya MO (2013) Consequences of WTO accession for the pharmaceutical industry in Russia. Space Time 1(11):125–131Google Scholar
  11. 11.
    Orlov AS (2014) Features of pricing on the Russian pharmaceutical market. New pharmacy. Effective Manag 10:18–23Google Scholar
  12. 12.
    Orlov AS (2014) Improving state regulation of prices on the Russian pharmaceutical market: using foreign experience in reference pricing. Econ Manag Sci Pract J 2(118):14–19Google Scholar
  13. 13.
    Sokolov BI, Lin AA, Orlov AS (2012) Pharmaceutical market: structural features in Russia. Prob Mod Econ 4:336–341Google Scholar
  14. 14.
    Sukhorukova MG (2016) Analysis of the pharmaceutical industry: problems and development prospects. Guide Businessm 29:254–262Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of Management, Economics and Finance of Kazan Federal UniversityKazanRussian Federation
  2. 2.Volga Region State Academy of Physical Culture, Sport and TourismKazanRussia
  3. 3.Russian State Social UniversityMoscowRussia

Personalised recommendations